The QualityStocks Daily Monday, January 6th, 2020

Today's Top 3 Investment Newsletters

Stock Market Watch (CTIB) +210.30%

BUYINS.NET (ZN) +138.31%

QualityStocks (CSHB) +65.12%

The QualityStocks Daily Stock List

AgJunction, Inc. (AJXGF)

OTC Markets, InvestorPoint, Silicon Investor, Central Charts, Macroaxis, Wallet Investor, GuruFocus, Stockhouse, Nasdaq, Stock Scores, Pink Investing, YCharts, Barchart, 4-Traders, and Seeking Alpha reported previously on AgJunction, Inc. (AJXGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AgJunction, Inc. (the Autosteering Company™) is an international leader of advanced guidance and autosteering solutions for precision agriculture applications. Its technologies are vital components in more than 30 of the world’s leading precision Ag manufacturers and solution providers. The Company was previously known as Hemisphere GPS, Inc. It changed its name to AgJunction, Inc. in May of 2013. Founded in 1990, AgJunction has its corporate headquarters in Scottsdale, Arizona.

AgJunction has shipped more than 100,000 systems globally. The Company markets its solutions under leading brand names. These including Novariant®, Wheelman®, Whirl™ and Handsfreefarm®. The Company works to bring affordable hands-free farming to every farm, regardless of terrain or size.

Autosteering is the basis for precision agriculture. It involves automatically and accurately steering a tractor on a predefined path, including turns, using GPS satellites. The untapped opportunity for GPS (GNSS) based Autosteering is 10 million farms worldwide.

AgJunction has deep roots in guidance and control. The Company has 200 patents and pending patents worldwide. In addition, it has 85 issued US Steering Patents. HandsFreeFarm® is AgJunction’s commitment to the prosperity of every farmer through the use of autosteering technology.

The Company provides engineered solutions to many of the world’s foremost implement and precision product manufacturers. Solutions include Guidance Solutions; GPS Components; Automated Steering Solutions; Embedded Software Applications; Application-specific Hardware; and Cloud Service Applications.

AgJunction’s historic brands include Beeline™, Novariant™, AutoFarm® and ParaDyme™. The Company is the autosteering intelligence behind products in the market today from more than 30 companies including manufacturers such as CLAAS and equipment providers such as Outback, AgLeader, and TeeJet.

AgJunction is focusing on making autosteer low-cost, simple-to-buy, as well as easy-to-use – the Aftermarket. It is also focusing on making autosteer an included feature on every new tractor – OEM (Original Equipment Manufacturer).

In December, AgJunction announced that it appointed Ms. Lori Ell, the Chair of the Company's Board of Directors, as Interim President and Chief Executive Officer of the Company, following the departure of Mr. David E. Vaughn as President and Chief Executive Officer.

Ms. Ell said, "Dave has accomplished much at AgJunction having knitted together a diverse group of companies, monetized non-core assets and rationalized operations in our new Scottsdale head office. More importantly, he has recruited a very strong leadership team who I look forward to working with through this transition.”

AgJunction, Inc. (AJXGF), closed Monday's trading session at $0.2852, up 16.4082%, on 1,000 volume with 2 trades. The average volume for the last 3 months is 18,062 and the stock's 52-week low/high is $0.224600002/$0.646000027.

chart

Columbia Care, Inc. (CCHWF)

The Cannabis Reporter, Market Screener, InvestorsHub, TradingView, InvestorX, Pot Stock News, New Cannabis Ventures, Stockhouse, Technical420, Seeking Alpha, MarketWatch, TipRanks, Investing.com, Wallet Investor, Stockwatch, Dividend.com, BioSpace, and GuruFocus reported beforehand on Columbia Care, Inc. (CCHWF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Columbia Care, Inc. operates in the medical cannabis industry in the USA and the European Union (EU). The Company provides a portfolio of high-quality cannabis-based health and wellness solutions. Its aim is to lead the industry through leveraging data and research to drive innovation and improve access to cannabis and plant-based solutions. Established in 2012, Columbia Care is based in New York, New York. The Company lists on the OTC Markets’ OTCQX.

Columbia Care has established partnerships with some of the world’s top research institutions, universities, and medical schools to further medical cannabis research. This allows for timely and relevant data collection and analysis, to boost future innovation. The Company has locations all across the United States. It has locations in Arizona, California, Delaware, Florida, Illinois, Massachusetts, New York, Pennsylvania, Puerto Rico, and Maryland.

Columbia Care’s patient-centric focus includes one-on-one consultations and follow-ups with pharmacists and experts. The Company offer brands and products that meet high standards of potency, purity, and predictability. Its proprietary, patent-pending medical brands are TheraCeed™, ClaraCeed™ and EleCeed™. These are pharmaceutical-quality and come in a variety of formats. These formats include hard-pressed tablets, suppositories, vapes, as well as lotions.

Columbia Care also offers an array of health and wellness brands and products in addition to its medical cannabis products. These include its own hemp CBD (cannabidiol) brands, which are full spectrum, independent 3rd party tested, organic, GMO-free, and produced in cGMP-compliant facilities. The Company’s flagship hemp CBD brand, Columbia Care Platinum Label, aims to set the standard in potency and purity.

Today, Columbia Care announced that it is one of 14 entities selected by the Utah Department of Health (UDOH) to dispense medical cannabis in the State. Columbia Care’s Springville dispensary is ideally located in the "Art City" within Utah County, the second most populous county in the State, providing the Company with access to more than 80 percent of the State’s residents. Via its Springville location, Columbia Care will introduce its differentiated, patient-centric experience designed to educate and serve those looking for high-quality, plant-based solutions to meet their unmet medical needs.

Moreover, today, Columbia Care provided an update on its Illinois operations. This includes initial results from adult use cannabis sales at its Chicago dispensary and the Company’s status as a minority partner in The Green Room Social Equity Partners LLC and Malcolm Partners LLC. Both groups qualify as social equity applicants in the Illinois new licensing process, being owned by partners with strong ties to their communities and the cannabis industry, with an intention of growing their own cannabis businesses.

Mr. Nicholas Vita, Chief Executive Officer of Columbia Care, said, "We are off to a great start in Illinois with initial results exceeding our expectations based on our experience in other markets that have converted from medical only to adult use. We believe the long-term impact on revenue to be three to four times prior medical-only levels. With the opening of our second Chicago location later this year leveraging our recently upgraded cultivation, manufacturing and packaging facility in Aurora, we are well positioned to meet increased demand for quality cannabis products, including flower, through both the wholesale and direct to consumer retail channels."

Columbia Care, Inc. (CCHWF), closed Monday's trading session at $2.76, up 7.6779%, on 39,778 volume with 40 trades. The average volume for the last 3 months is 17,585 and the stock's 52-week low/high is $1.60185003/$7.19910001.

chart

Community Shores Bank Corporation (CSHB)

Zacks, Street Insider, Seeking Alpha, InvestorGuide.com, Wallet Investor, OTC Markets, 4-Traders, Stockwatch, Simply Wall St, RocketReach, Dividend Investor, TeleTrader, TradingView, last10k, and InvestorsHub reported earlier on Community Shores Bank Corporation (CSHB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Community Shores Bank Corporation is the bank holding company of Community Shores Bank. The Bank is the only independent community bank with headquarters in Muskegon, Michigan. The bank serves businesses and consumers in the western Michigan counties of Muskegon and Ottawa from four branch offices. Community Shores Bank Corporation lists on the OTC Markets. Established in 1998, Community Shores Bank Corporation serves individuals, businesses, schools, associations, churches, non-profit organizations, financial institutions, and government authorities.

The Bank provides diverse deposit services. This includes checking and savings accounts, time deposits, certificates of deposit, and individual retirement accounts. The Bank’s loan portfolio consists of fixed rate and adjustable rates loans, construction loans and loans for condominiums; home equity loans; and construction permanent loans.

In addition, the Bank provides installment loans and credit lines, including automobile loans, boat loans, recreational vehicle loans, home improvement loans, personal loans, and personal lines of credit; credit cards; and business loans, including small business lines of credit, term loans commercial real estate loans, letters of credit, and SBA loans. Furthermore, Community Shores Bank provides electronic and mobile banking services; overdrafts; re-order checks, wire transfers, safe deposit boxes, notary services, ATM and one-time debit card overdraft opt-in, gift cards, and courier services; and investment products.

Today, ChoiceOne Financial Services, Inc. (OTC: COFS), the parent company of ChoiceOne Bank and Lakestone Bank & Trust, and Community Shores Bank Corporation jointly announced the signing of a definitive merger agreement whereby ChoiceOne will acquire Community Shores Bank. The combination, a stock and cash transaction, will create a roughly $1.5 billion asset bank holding company with 33 offices in West and Southeastern Michigan.

The expectation is that this transaction will close in Q2 of 2020, subject to the satisfaction of customary closing conditions. This includes receipt of approval from Community Shores Bank shareholders and receipt of regulatory approvals. The transaction was unanimously approved by the Boards of Directors of both companies.

Community Shores Bank Corporation (CSHB), closed Monday's trading session at $4.97, up 65.1163%, on 169,964 volume with 306 trades. The average volume for the last 3 months is 327 and the stock's 52-week low/high is $2.22000002/$5.15000009.

chart

FingerMotion, Inc. (FNGR)

Stock Target Advisor, OTC Markets, Capital Cube, Stockwatch, Investors Hangout, Stockhouse, Real Investment Advice, Trading View, InvestorsHub, Street Insider, Simply Wall St, and Wallet Investor reported beforehand on FingerMotion, Inc. (FNGR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

FingerMotion, Inc. is a U.S. FinTech (Financial Technology) company with mobile payment and recharge platform operations in the People’s Republic of China (PRC). It is one of five companies in China with access to wholesale rechargeable minutes by way of top-up credits on the mobile phone. The Company’s vision is to quickly grow its user base via organic means and have this growth develop into an ecosystem of users with high engagement rates using its unique applications.

JiuGe Information Technology is FingerMotion’s wholly-owned Chinese subsidiary. FingerMotion has its head office in China. The Company’s shares trade on the OTC Markets Group’s OTCQB.

FingerMotion is investing in research and development (R&D). Its chief area of emphasis is the development of “must have” applications for consumers and businesses. Its longer term focus is to develop a marketing platform capable of leveraging all the meta data collected by the leading telcos into a predictive model, which is able to isolate and extract consumer behavior and habits for future monetization.

FingerMotion is developing value added technologies to market to its users. The Company ultimately hopes to serve more than 1 billion users in the China market and eventually expand the model to other regional markets.

In late October 2019, FingerMotion announced its financial results for the quarter ended August 31, 2019. Chief Executive Officer, Mr. Martin Shen, said, “I am very pleased with the improvement in our JiuGe subsidiary, as we posted our first ever gross profit for the quarter. We believe this achievement has elevated us to an elite class of Chinese e-commerce businesses that have reached profitability.”

The latest financial results reflect an improved balance sheet and quarter-over-quarter growth. FingerMotion maintained momentum in their Revenues mainly driven by their strategic partnerships regarding top-up growth. Its Gross Transaction Volume (GTV) for Q2 was $181 million. This represents a 15 percent quarter over quarter increase in comparison to the $157 million realized in Q1. This translates to an annual run rate of $722 million.

The Company stated that the SMS business is also gaining noticeable traction. Moreover, the JiuGe subsidiary was awarded contracts to market China Mobile’s products and services online, in ShanXi and SiChuan provinces, which have a combined population of greater than 115 million people.

FingerMotion, Inc. (FNGR), closed Monday's trading session at $0.67, off by 27.1739%, on 1,900 volume with 5 trades. The average volume for the last 3 months is 2,648 and the stock's 52-week low/high is $0.60009998/$9.4499998.

chart

IDW Media Holdings, Inc. (IDWM)

NetworkNewsWire, Zacks, Stock News Now, Equities, Proactive Investors, OTC Markets, Simply Wall St, Stockhouse, YCharts, InvestorsHub, MacroTrends, Wallet Investor, and GuruFocus reported previously on IDW Media Holdings, Inc. (IDWM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IDW Media Holdings, Inc. is an integrated media company listed on the OTC Markets. Its businesses include IDW Publishing, IDW Entertainment, and CTM Media Group. The Company previously went by the name CTM Media Holdings, Inc. It changed its name to IDW Media Holdings, Inc. in July of 2015. Formed in 2009, IDW Media Holdings has its corporate office in Newark, New Jersey.

The Company’s IDW Publishing is a a foremost American publisher of comic books and graphic novels. IDW Entertainment is a producer and distributor of franchise content through television and other media. CTM Media Group is one of North America's largest distributors of information for tourists and travelers.

Fundamentally, IDW Media Holdings companies provide a broad range of entertainment products globally. Comic books, television shows, gallery showings, board games, collectible books, and original art are all part of the Company’s offerings.

On November 21, 2019, during a keynote presentation at the NCTE (National Council of Teachers of English) opening ceremony, author, actor and activist Mr. George Takei announced that his New York Times bestselling graphic memoir They Called Us Enemy will be published in Spanish in North America as part of a new Spanish language initiative from IDW Publishing, a division of IDW Media Holdings.

Chris Ryall, IDW’s President, Publisher and CCO, said, “IDW is proud to announce our new publishing initiative that reflects the increasingly diverse makeup of American readers and expands the accessibility of graphic novel storytelling to Spanish-speaking communities throughout the United States, Mexico and Canada.”

In December, IDW Media Holdings announced that Mr. Chris McGurk joined the Company's Board of Directors. Mr. McGurk is the Chairman and Chief Executive Officer (CEO) of Cinedigm (CIDM). He has served as the Chairman and CEO of Cinedigm since 2011. Before joining Cinedigm, he founded Overture Films and served as its CEO and as CEO of Anchor Bay Entertainment, which distributed Overture Films' product to the home entertainment industry.

IDW Media Holdings, Inc. (IDWM), closed Monday's trading session at $8.00, up 6.6667%, on 3,513 volume with 12 trades. The average volume for the last 3 months is 7,588 and the stock's 52-week low/high is $6.21000003/$35.9099998.

chart

Simplicity Esports and Gaming Company (WINR)

Investor Ideas, Penny Stock Base, GlobeNewswire, and MarketWatch reported earlier on Simplicity Esports and Gaming Company (WINR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Simplicity Esports and Gaming Company is an established brand in the esports industry. The Company has an engaged fan base competing in popular games across varied genres. These include PUBG, Fortnite, League of Legends, Overwatch, Gears of War, Smite, and numerous EA Sports titles. The OTCQB-listed Company previously went by the name Smaaash Entertainment, Inc. It changed its name to Simplicity Esports and Gaming Company in January of 2019. Incorporated in 2017, Simplicity Esports and Gaming is headquartered in New York, New York.

Additionally, the Company operates Esports Gaming Centers. These provide the public an opportunity to experience and enjoy gaming and esports in a social setting, regardless of skill or experience. Essentially, Simplicity Esports and Gaming is an international virtual reality gaming and fully integrated eSports platform business.

The Company is an emerging operator and developer of family entertainment centers across the United States. It combines proprietary sports, eSports, virtual and augmented reality gaming, as well as dining into a highly interactive and unique social experience for family and friends. Simplicity Esports’ completely integrated eSports platform concept will include the development of dedicated eSports centers throughout the nation, alongside the management of eSports teams at all competitive levels.

Simplicity Esports and Gaming Company acquired PLAYlive Nation, Inc. in 2019. PLAYlive has a network of franchised Gaming Centers throughout numerous States, including but not limited to, California, Washington, Arizona, and Texas.

Last week, Simplicity Esports and Gaming announced the opening of a new franchise gaming center at SouthPark Mall in Strongsville, Ohio. The 2,561 square foot location has 36 gaming stations, consisting of consoles and PCs. This new location also offers concessions, a variety of gaming merchandise, as well as accessories.

Today, Simplicity Esports and Gaming announced that it chose OutField Consulting to serve as a consultant for sponsorships and business development in the U.S. market, and also in Brazil. Outfield Consulting is a Brazilian-based sports marketing firm. OutField has a strong record of accomplishment in the esports market in Latin America, having worked with leading teams, brands and specialized agencies.

Simplicity Esports and Gaming Company (WINR), closed Monday's trading session at $1.03, up 0.980392%, on 3,116 volume with 7 trades. The average volume for the last 3 months is 3,391 and the stock's 52-week low/high is $0.560000002/$6.61999988.

chart

Two Rivers Water & Farming Company (TURV)

Green Rush Review, Zacks, Insider Financial, Last10k, Investing.com, Wallet Investor, TMXmoney, The Marijuana Investor, Simply Wall St, Transparent Traders, Investor Village, Morningstar, Stocks Newswire, Daily Marijuana Observer, TipRanks, Market Screener, OTC Markets, GuruFocus, GlobeNewswire, Stockhouse, Nasdaq, InvestorsHub, and TradingView reported earlier on Two Rivers Water & Farming Company (TURV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is a vertically integrated agricultural, water rights, and consumer products company. It is pursuing a mission to become a leading hemp-based seed-to-sale operator. The Company owns agricultural land and water rights in Southern Colorado where it grows varied strains of hemp with proprietary genetics. Its land and water assets include more than 2,500 acres of agricultural land and more than 1,500 square miles of drain water rights. OTCQB-listed, Two Rivers Water & Farming Company (TURV) is headquartered in Aurora, Colorado.

The Company has a brand portfolio of premium natural supplements. This includes CBD (cannabidiol). By way of its consumer brand subsidiary, Gramz LLC, it develops leading products in different categories, including CBD.

In addition, TURV has operational expertise in hemp production and distribution. Its subsidiary is Vaxa Global. Vaxa’s management team has decades of experience in agricultural operations. This includes hemp production and manufacturing.

TURV is positioned to grow different strains of hemp with proprietary genetics, to sell bulk biomass, process and extract phyto-cannabinoids and to develop and distribute consumer products. It has developed a line of proprietary products founded on a unique first-to-market Nature’s Whole Spectrum™ approach. The Company plans to monetize its diverse asset base of land and water through recently acquired hemp companies to form an integrated seed-to-sale enterprise.

This past November, TURV released a letter from the Company’s Interim Chief Executive Officer, Mr. Greg Harrington. Mr. Harrington noted that TURV’S objective remains to deliver value to shareholders through re-positioning the Company’s assets and restructuring its obligations.

TURV is continuing to develop its feminized seed propagation programs for the spring planting season. The Company has greater than 3,000 high-CBD genetic mothers in a greenhouse that it will continue to propagate throughout the winter and into the 2020 spring planting season. TURV is on pace to propagate up to half a million feminized seeds for its farming operations in Walsenburg, Colorado.

Two Rivers Water & Farming Company (TURV), closed Monday's trading session at $0.0706, off by 3.9456%, on 477,756 volume with 31 trades. The average volume for the last 3 months is 260,004 and the stock's 52-week low/high is $0.059459999/$0.735000014.

chart

GeoVax Labs, Inc. (GOVX)

StreetWise Reports, Zacks, Street Insider, Investor Village, Stock News Now, Micro Cap Daily, OTC Markets, Stockwatch, Marketbeat, Real Investment Advice, InvestorsHub, Stockhouse, and Proactive Investors reported previously on GeoVax Labs, Inc. (GOVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, GeoVax Labs, Inc. is a biotechnology company developing human vaccines. The Company is developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. GeoVax Labs current development programs are centered on preventive vaccines against HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, and also therapeutic vaccines against chronic Hepatitis B infections and numerous cancers. GeoVax Labs has its head office in Smyrna, Georgia.

MVA is a large virus capable of carrying a number of vaccine antigens. On the platform, MVA expresses proteins that assemble into VLP immunogens within (in vivo) the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines elicit durable immune responses in the host alike to a live-attenuated virus. This is while providing the safety characteristics of a replication-defective vector.

GeoVax Labs has designed the leading preventative HIV vaccine candidate to fight against the subtype of HIV predominant in the larger commercial markets of the Americas, Western Europe, Japan, and Australia. At present, this program is undergoing human clinical trials managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH). Additionally, the Company’s HIV vaccine is part of collaborative efforts to develop an immunotherapy as a functional cure for HIV.

Recently, GeoVax Labs announced its observance of HIV Vaccine Awareness Day on May 18, 2019. HIV Vaccine Awareness Day is observed each year to recognize the many volunteers, community members, health professionals, and scientists working to develop a vaccine to prevent HIV. Furthermore, it is an opportunity to educate communities about the importance of preventive HIV vaccine research.

GeoVax Labs also recently announced that it will be engaged in corporate partnering meetings during the BIO International Convention, to take place in Philadelphia, Pennsylvania on June 3-6, 2019. The Company was selected by the National Institutes of Health (NIH) and BIO to exhibit and showcase its technology in a high-profile area of the exhibition floor branded as the Innovation Zone, dedicated to recipients of NIH SBIR/STTR grants.

GeoVax Labs, Inc. (GOVX), closed Monday's trading session at $0.00045, up 50.00%, on 87,012,437 volume with 125 trades. The average volume for the last 3 months is 22,531,089 and the stock's 52-week low/high is $0.0003/$3.58999991.

chart

ImageWare Systems, Inc. (IWSY)

NetworkNewsWire, Zacks, Stock News Now, Tip Ranks, Micro Cap Daily, Marketwired, Super Stock Screener, Stockhouse, Marketbeat, YCharts, Insider Financial, Simply Wall St, Infront Analytics, Insider Tracking, 4-Traders, Stockopedia, InvestorsHub, Market Screener, and Wallet Investor reported previously on ImageWare Systems, Inc. (IWSY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, ImageWare Systems, Inc. is a leader in mobile and cloud-based, multi-modal biometric identity management solutions. The Company provides two-factor, biometric and multi-factor authentication solutions for the enterprise. ImageWare delivers next-generation biometrics as an interactive and scalable cloud-based solution. ImageWare Systems is based in San Diego, California, with offices in Portland, Oregon; Ottawa, Ontario; Tokyo, Japan; and Mexico City, Mexico.

The Company’s products support multi-modal biometric authentication. This includes, but is not limited to, face, voice, fingerprint, iris, palm, and more. All of the biometrics can be combined with or used as replacements for authentication and access control tools, including tokens, digital certificates, passwords, and PINS, to provide the supreme level of assurance, accountability, and user-friendliness for corporate networks, web applications, mobile devices, and PC desktop environments.

ImageWare Systems’ patented biometric authentication solutions offer everything from turnkey solutions to totally customized, white-label apps. Its products include GoVerifyID® Enterprise Suite; IWS GoVerifyID®; IWS CloudID®; IWS Biometric Engine®; IWS Law Enforcement; The Pillphone®; and IWS Credentialing (Identification Badge Software Development Solutions).

ImageWare Systems solves the problem that is responsible for greater than 80 percent of corporate data breaches through replacing or strengthening passwords with a client’s choice of biometrics and other multi-factor authentication methods. Therefore, this provides the highest level of user assurance, security and user convenience. ImageWare’s Digital Identity Platform provides customers and partners with access to its patented technology for ultra-scalable and anonymous biometrics using almost any vendors’ biometrics.

In November 2018, ImageWare® Systems announced the GoVerifyID® Digital Identity Transformation Platform as part of its GoVerifyID Enterprise Suite product line. The new platform and turnkey solution provide federated digital identity onboarding, digital identity proofing, digital rights management, digital contracting, document signing, digital vaults, and overall digital identity management. It does so while providing support for regulatory and privacy compliance across numerous industries and geographies or digital ecosystems all from the same platform.

The ImageWare Digital Identity Platform is constructed upon highly patented biometric capabilities. It is a seamlessly integrated collection of products, which provides the broadest set of biometric authentication factors combined with the most robust identity proofing capabilities. The ImageWare Digital Identity Platform™ is an end-to-end digital biometric identity proofing, authentication and lifecycle management solution. The platform provides the widest set of identity validation and biometric authentication capabilities in the industry.

This past February, ImageWare Systems announced an agreement in an 8-K filing that an international financial services provider selected the Company to provide multi-modal biometric authentication solutions for a healthcare application (used to comply with mandates under the 21st Century Cures Act).

In March, in an 8-K filing, ImageWare announced a contract award via its partner Contactable. This contract is to provide biometric authentication to a major multinational mobile telecommunications company. Also, ImageWare Systems’ GVID Biometric Platform was chosen to secure international cloud authentication for a24.io, and Gatekeeper Innovation and ImageWare announced a partnership to address the opioid epidemic and improve patient outcomes.

At the beginning of April, ImageWare® reported financial results for Q4 and year-ended December 31, 2018. The Revenue for both periods mainly reflects the Company’s legacy business. Revenue for Q4 ended December 31, 2018 was $1.1 million versus $1.2 million in Q4 2017. Net Loss from Continuing Operations was ($3.1 million) in the quarter versus ($2.4) million in Q4 2017.

Revenue for the year ended December 31, 2018 grew 2.6 percent to $4.4 million versus $4.3 million for the year ended 2017. Net Loss for the year was ($12.6 million) in 2018 versus ($10.1 million) in 2017.

ImageWare Systems, Inc. (IWSY), closed Monday's trading session at $0.431, up 30.8042%, on 169,974 volume with 65 trades. The average volume for the last 3 months is 156,617 and the stock's 52-week low/high is $0.230000004/$1.79999995.

chart

Mechanical Technology, Incorporated (MKTY)

Zacks, Wallet Investor, Tech Stock Standard, Business Wire, Last10k, InvestorsHub, Marketbeat, Biz Journals, Simply Wall St, YCharts, The Street, MarketWatch, Dividend Investor, Marketwired, and Market Screener reported previously on Mechanical Technology, Incorporated (MKTY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mechanical Technology, Incorporated engages in the design, manufacture, and sale of test and measurement instruments and systems via its subsidiary MTI Instruments Incorporated. It designs, manufactures, and markets precision linear displacement solutions, vibration measurement and system balancing solutions, precision tensile measurement systems, and wafer inspection tools globally. The Company lists on the OTC Markets. Established in 1961, Mechanical Technology has its head office in Albany, New York.

MTI Instruments’ products use a complete variety of technologies to solve complex, real world applications in manifold industries. These industries include manufacturing, electronics, semiconductor, solar, commercial and military aviation, automotive and data storage.

MTI offers electronic gauging instruments for position, displacement, and vibration applications in the industrial manufacturing/production markets, and the research, design, and process development market. Additionally, MTI provides engine balancing and vibration analysis systems for military and commercial aircraft; and metrology tools for semiconductor and solar wafer characterization. It also provides tensile stage systems for materials testing and precision linear displacement gauges for use in academic and industrial research and development settings.

Recently, Mechanical Technology announced its financial results for 2018. Revenue increased $1.0 million, or 14 percent, to $8.1 million in 2018 because of increased activity with the U.S. government. The Company continues to expand its PBS product offerings within existing and new Air Force, Navy and Coast Guard programs. The Company also continued to grow its commercial engine balancing system and accessories business, most notably in engine test cell facilities worldwide.

Operating Income grew $935,000 in 2018 to $1.5 million. This is the highest level reported by the Company since 1998. Spending on new development initiatives and product enhancements at its MTI Instruments subsidiary intensified in 2018 as part of Mechanical Technology’s commitment to grow organically. Therefore, 2019 will see the introduction of new capacitance products and an updated model of the Company’s renowned engine vibration balancing system.

Mechanical Technology, Incorporated (MKTY), closed Monday's trading session at $0.99, up 46.5581%, on 26,640 volume with 21 trades. The average volume for the last 3 months is 6,591 and the stock's 52-week low/high is $0.610000014/$1.70000004.

chart

Patriot Gold Corp. (PGOL)

Investopedia, The Street, Proactive Investors, Stockwatch, Barchart, Dividend Investor, YCharts, Wallet Investor, Real Pennies, OtcWizard, Standout Stocks, Marketwired, and Gold Investment Letter reported beforehand on Patriot Gold Corp. (PGOL), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Patriot Gold Corp. is a precious metals exploration and production company listed on the OTC Markets’ OTCQB. Its mission is to discover and develop significant gold and silver assets in Arizona and Nevada. Currently, the Company holds a portfolio of four projects. These are the Moss project in Arizona and three in Nevada (Bruner, Vernal, and Windy Peak). Patriot Gold is based in Las Vegas, Nevada.

The Company holds a 3 percent royalty in the Moss Mine in Arizona, an interest in the Bruner gold project in Nevada, and a 100 percent interest in the Windy Peak and Vernal projects in Nevada. The Moss Mine Project is within the historic Oatman District, 10 miles east of Bullhead City, Arizona and roughly 70 miles southeast of Las Vegas. Northern Vertex Mining Corp. is the owner of the Moss Mine. The Moss Mine entered commercial production as of the beginning of September 2018.

The Vernal gold project is in its early stage. This property is approximately 140 miles east-southeast of Reno, Nevada, on the west side of the Shoshone Mountains. This property comprises 12 unpatented mining claims (240 acres).

The Windy Peak Gold Project comprises 79 unpatented mineral claims in the Fairview mining district in southwest Nevada. Windy Peak is easily accessed. It is about 45 miles southeast of Fallon and 6 miles from Middlegate.

Patriot Gold owns a 2 percent royalty in the Bruner gold project. The Bruner gold project property is approximately 130 miles east-southeast of Reno, Nevada. It is at the northern end of the Paradise Range and 45 miles northwest of the Round Mountain Mine. Canamex Resources Corp. is the owner of the Bruner gold project.

The Bruner and Vernal gold projects are in Nevada's Walker Lane, which hosts many major deposits. These include the Goldfield (more than 5 million ounces of post production and current reserves) and the Comstock (more than 8 million ounces).

Recently, Patriot Gold announced that it completed an initial phase of drilling exploration at the Windy Peak Project in Churchill County, Nevada, beginning in September 2018. At present, the Windy Peak deposit is interpreted as a low-sulfidation, epithermal gold deposit positioned marginal to and likely associated with a caldera ring fracture zone.

Intersections between ring fractures and regional normal faults in the Windy Peak Project area are especially favorable exploration targets. They offer the unique combination of fluid conduits and structural controls known to concentrate high-grade mineralization.

Patriot Gold Corp. (PGOL), closed Monday's trading session at $0.05, up 35.1351%, on 24,053 volume with 8 trades. The average volume for the last 3 months is 13,762 and the stock's 52-week low/high is $0.031099999/$0.150000005.

chart

Vegalab, Inc. (VEGL)

OTC Markets, GuruFocus, Simply Wall St, YCharts, Investors Hangout, Stockwatch, Capital Cube, InvestorsHub, TradingView, Business Insider, PennyStockHub, Wallet Investor, Barchart, MarketWatch, InvestingNewsAlerts, Stockhouse, and Stockopedia reported earlier on Vegalab, Inc. (VEGL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. Its products support a healthy soil biome. Additionally, they are cost competitive with synthetic chemicals that do just the opposite. The Company’s products include Biocontrol Agents, Insecticides, Fungicides, Soil Inoculants, and Fertilizers. Vegalab has its corporate office in North Palm Beach, Florida.

Vegalab operates in two segments of the food industry. These are the Agronomy Business and the Packing Business. The Agronomy Business involves the manufacture and distribution of all-natural crop protection, crop health, and soil enhancement products. The Packing Business operates a citrus packing facility.

All of the Company’s oil-based products go through a process of micronization. This gives the oils the ability to cover a larger surface area and enables deeper penetration into the crevices of plants, insects, and pathogens. The minute pores and filaments in the plant absorb Vegalab’s products faster versus conventional oils.

Vegalab’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Every Vegalab product strives to enhance productivity and lessen waste.

In October 2017, Vegalab purchased M&G Packing. The facility consists of approximately 11 acres of real property and 30,000 sq. ft. of buildings. In March 2018, Vegalab announced that it completed its acquisition of The Agronomy Group, LLC effective as of February 1, 2018. The Agronomy Group (TAG) is located in Tulare County, California. It is a producer and distributor of environmentally friendly agrochemicals and also distributes other products.

In November 2018, Vegalab announced the acquisition, subject to a lease option agreement that runs through November 1, 2019, of a major fruit packing facility in Lindsay, California. The facility (on 9.4 acres in California’s San Joaquin Valley) comprises greater than 260,000 square feet of working space. This includes three packing lines, roughly 32,000 square feet of cold storage, 12 de-greening rooms, and a 6 bay shipping area.

This facility will significantly increase Vegalab’s present capacity to process and pack fruit. Vegalab’s management team believes the acquisition will boost the Company’s overall fruit processing capacity to more than US $150 million annually. The current capacity at the facility is about 200 bins per hour.

Recently, Vegalab announced it will start selling its products via all three locations of Pratum Co-op, a well-known and fast growing agricultural retailer based in the diverse growing region of the Willamette Valley in Oregon. Pratum Co-op is a supplier of fertilizer, crop protection and petroleum products. Pratum has three state of the art locations to serve its members who are prominent growers of grass seeds, blueberries, hazelnuts, grapes, hay, carrot seed and more.

Vegalab, Inc. (VEGL), closed Monday's trading session at $0.10, up 42.8571%, on 199 volume with 1 trade. The average volume for the last 3 months is 916 and the stock's 52-week low/high is $0.009999999/$1.50.

chart

Esports Entertainment Group, Inc.  (GMBL)

Stockrow, Real Pennies, Dividend Investor, Proactive Investors, Capital Network, Infront Analytics, YCharts, OTC Markets, RedChip, Marketbeat, TradingView, Capital Cube, and Wallet Investor reported earlier on Esports Entertainment Group, Inc. (GMBL), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

Esports Entertainment Group, Inc. is a next generation, licensed, online gambling business especially focused on esports wagering. Its plan is to offer wagering on esports events in a fully licensed, regulated, and secured platform to the global esports audience, excluding the United States. Esports Entertainment Group has offices in St. Mary's, Antigua, and Barbuda.

Last week, Esports Entertainment Group announced the hiring of two key executives and the opening of its new international headquarters in Malta. Malta was selected because of its strategic location within the European Union (EU), and also access to a highly educated and multi-lingual workforce, particularly in the fields of online gambling.

The Company’s plan is to offer users around the world the ability to participate in multi-player video games tournaments online for cash prizes. At present, the Company is developing several play money websites and its real money wagering website.  

Esports Entertainment is a licensed online gambling business with a particular emphasis on esports wagering and 18+ gaming. The Company’s online esports gambling platform will be completely licensed and the highest regulated esports gambling site worldwide.

The Company has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission. Esports has applied for an Interactive Wagering License with the Financial Services Regulatory Commission of Antigua and Barbuda to conduct real money interactive gaming on a worldwide basis from centers in Canada and Antigua.

Esports Entertainment has an agreement with PartnerMatrix. This is the first platform that enables online sportsbook and casino operators to run Affiliate System with Agent functionality and Agent System with Affiliate functionality. With the agreement, Esports Entertainment Group will integrate the PartnerMatrix platform to manage its affiliate program on an expedited basis. Esports Entertainment Group has also launched vie.gg. This is the world’s first and most transparent esports betting exchange.

Recently, Esports Entertainment Group announced Affiliate Marketing Agreements with 14 more esports teams as it continues to ramp up affiliate marketing activities in support of its launch of vie.gg. The addition of these 14 esports teams brings the total number of esports team affiliates to 190 since the Company’s first announcement on April 5, 2018.

Esports Entertainment Group, Inc. (GMBL), closed Monday's trading session at $0.43, up 53.5714%, on 122 volume with 3 trades. The average volume for the last 3 months is 32,617 and the stock's 52-week low/high is $0.200000002/$1.04999995.

chart

Wealthcraft Capital, Inc. (WCCP)

OTC Markets, MarketWatch, InvestorsHub, 4-Traders, Stockhouse, Simply Wall St, WalletInvestor, Penny Stock Hub, Penny Stock Tweets, Barchart, Stock Target Advisor, InvestorPlace, and Silicon Investor reported on Wealthcraft Capital, Inc. (WCCP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Wealthcraft Capital, Inc. concentrates on the investment of capital in private companies, which are interested in expanding their business through gaining better access to capital, management consulting, as well as business development. Mr. Adam D. Sexton is the President and Chief Executive Officer (CEO) of the Company.

Mr. Sexton is an experienced business, entertainment, and digital media leader. He has wide-ranging experience launching and operating disruptive digital products and services for worldwide entertainment, technology industry leaders, as well as start-ups.

Wealthcraft Capital was previously known as Wealthcraft Systems, Inc. It changed its name to Wealthcraft Capital, Inc. in February of 2017. The Company’s shares trade on the OTC Markets Group’s OTCQB. Wealthcraft Capital has its corporate headquarters in Los Angeles, California.

Last week, WealthCraft Capital announced the acquisition of a majority interest in Geaux Industries in exchange for $1,000,000 of the Company’s common stock at market value. Geaux Industries is a provider of security services for commercial, retail and industrial customers, with customized services and special patrol methods applicable for the cannabis industry.

Geaux Industries is licensed by the California Department of Consumer Affairs. For selected security operations, Geaux does business under the franchised name of Signal 88 Security. The exchange agreement provides for Wealthcraft Capital to acquire the minority interest, under certain terms and conditions.

Mr. Sexton said, “With the legalization of recreational cannabis in California on January 1, 2018, the Company believes that there is a significant market opportunity for Geaux Industries to be one of the leading providers of specialized security services.”

Geaux Industries will continue to address the market with inventive new technologies and services and creative business models for the traditional and non-traditional businesses.

At the closing, Wealthcraft Capital CEO, Adam Sexton, was appointed to fill a vacancy on the Board of Directors of Geaux Industries.

Wealthcraft Capital, Inc. (WCCP), closed Monday's trading session at $0.2, up 53.7279%, on 171 volume with 1 trade. The average volume for the last 3 months is 1,835 and the stock's 52-week low/high is $0.052000001/$0.899999976.

chart

The QualityStocks Company Corner

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced the unanimous appointment of Pam Prior, CPA, to its Board of Directors. To view the full press release, visit http://nnw.fm/Xo66O.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Monday's trading session at $2.50, up 7.2961%, on 38,686 volume with 228 trades. The average volume for the last 3 months is 31,582 and the stock's 52-week low/high is $2.28999996/$8.50.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX, Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, offers a California Consumer Privacy Act (CCPA) compliant data set. CCPA became effective on January 1, 2020, and according to major news sources most companies are not yet compliant or prepared for the impact CCPA will have.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $2.35, up 6.8182%, on 60,695 volume with 313 trades. The average volume for the last 3 months is 129,872 and the stock's 52-week low/high is $1.04999995/$5.8499999.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings (OTCQB: NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, today announced its plans to exhibit at the 44th Annual Hotel, Motel & Restaurant Supply Show of the Southeast on January 28-30, 2020. To view the full press release, visit http://nnw.fm/v3oGO.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Monday's trading session at $0.2331, up 0.474138%, on 80,531 volume with 17 trades. The average volume for the last 3 months is 126,858 and the stock's 52-week low/high is $0.199650004/$0.920000016.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings (OTC: MCTC), a cannabinoid science forward company developing unique hemp infusion technologies, today announced Hemp You Can Feel(TM) Coffee. According to the update, the new product is based on MCTC’s patent-pending hemp extract infusion technologies. To view the full press release, visit http://cnw.fm/9HnnK

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Monday's trading session at $0.28, up 7.6923%, on 332 volume with 4 trades. The average volume for the last 3 months is 10,407 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs Inc. (NASDAQ: SGLB) President and CEO John Rice recently joined NNW’s Stuart Smith to discuss the company’s disruptive technology (http://nnw.fm/2DNrE). A leading developer of quality-control software for the commercial 3D-printing industry, SGLB offers PrintRite3D® software: a proprietary, real-time, computer-aided inspection (CAI) technology. The product is unique as the only in-process, quality-assurance software that revolutionizes the commercial 3D metal-printing industry by enabling nondestructive quality control intervention during the production process.

Software companies can prove to be exceptionally lucrative and rewarding when they provide critical solutions to complex problems. Sigma Labs Inc. (NASDAQ: SGLB) is in just such an enviable position. The company is the recognized pioneer in the development and commercialization of real-time, computer-aided inspection solutions for the 3D metal printing industry.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Monday's trading session at $1.0188, up 3.034%, on 19,959 volume with 89 trades. The average volume for the last 3 months is 197,164 and the stock's 52-week low/high is $0.451099991/$2.46000003.

Recent News

chart

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

Cord cutters have gained a growing measure of control on-the-go over their entertainment choices thanks to the rise of streaming video services, creating the seeds of a free-the-cable-box future and more democratic approach to film studio production in the process. British Columbia-based film production house Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) is taking advantage of streaming consumers’ openness to “indie” entertainment options that don’t have the trappings of a blockbuster franchise, bringing developed scripts with celebrity backing to the screen using a strategic budget model that aims to turn significant profits from controlled front-end costs.

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Monday's trading session at $0.12, even for the day, on 63,690 volume. The average volume for the last 3 months is 61,339 and the stock's 52-week low/high is $0.072099998/$0.452270001.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its Board of Directors (the “Board”) has, effective immediately, named Colin Moore, director of the Company and former president of Starbucks Coffee Canada, as interim president and chief executive officer. To view the full press release, visit http://cnw.fm/PP1Eu

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.475, off by 1.6563%, on 314,895 volume with 240 trades. The average volume for the last 3 months is 498,216 and the stock's 52-week low/high is $0.432000011/$1.7888.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) was featured today in a publication from HempWireNews, examining how hemp is an extremely versatile crop, said to have thousands of uses. The plant’s uses range from industrial applications like making bioplastic and construction materials, to nutritional uses. Not to mention the plethora of cannabinoids it produces, such as cannabidiol (CBD) and cannabigerol (CBG), which have their own wide-ranging applications.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.3613, off by 3.2664%, on 93,812 volume with 49 trades. The average volume for the last 3 months is 98,024 and the stock's 52-week low/high is $0.354999989/$1.6875.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com Inc. (OTCQB: CIIX)CEO Warren Wang spoke optimistically about his company’s growth potential in a recent MoneyTV interview with host Donald Baillargeon. Wang said the company would focus in 2020 on building more revenue from high margin products and cutting costs to achieve profitability. He also emphasized the important role subsidiary CBD Biotech and CBD-infused cosmetics products would play in China.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Monday's trading session at $0.16145, off by 10.3056%, on 33,362 volume with 23 trades. The average volume for the last 3 months is 52,532 and the stock's 52-week low/high is $0.150000005/$0.550000011.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders Inc. (OTC: NBDR) was featured today in the 420 with CNW by CannabisNewsWire. California is the largest marijuana market in the U.S., so it is worthwhile to look forward and see what is in the works for this state’s cannabis industry in the new year. Here are some of the major things that could pan out in 2020.

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Monday's trading session at $0.0135, off by 9.2742%, on 6,923 volume with 3 trades. The average volume for the last 3 months is 63,819 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Singlepoint Inc. (OTCQB: SING), which specializes in acquisitions of small to mid-sized companies with an emphasis in new technologies, is celebrating results from an impressive Q3 resulting from multiple strategic ventures. The recent acquisition of Direct Solar, product launches of PURE hemp products and distribution agreements within the hemp industry are providing investors opportunity across a wide range of assets.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.0076, off by 3.1847%, on 3,352,529 volume with 114 trades. The average volume for the last 3 months is 3,039,302 and the stock's 52-week low/high is $0.007/$0.0259.

Recent News

chart

OriginClear (OTC: OCLN)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLN).

A foremost provider of water-treatment solutions, OriginClear Inc. (OTC: OCLN)offers modular water-treatment and conveyance products that enable water independence and help make clean water available for all. Recently, the company’s CEO Riggs Eckelberry was featured in a television interview discussing OriginClear’s recent success and upcoming initiatives.

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

In just 10 years, the global water services market has doubled into a trillion-dollar industry, driven by improper sanitation and water scarcity. Only 20 percent of all sewage and only 30 percent of all industrial waste are ever treated. Additionally, water leakage results in the loss of 35 percent of all clean water across the planet; reducing that percentage by half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

The statistics demonstrate that we can no longer rely on the efficiencies of giant, centralized water utilities to meet these challenges. An increasing number of businesses are starting to take notice, instead conducting their own water treatment and recycling. Whether by choice or out of necessity, those businesses that do invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of the public’s eye and with OriginClear’s help, a growing number of self-reliant businesses are building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which represent $22 trillion of assets under management around the world, specifically note the key indicator of how well corporations manage their water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLN), closed Monday's trading session at $0.18, up 24.0524%, on 20,583 volume with 16 trades. The average volume for the last 3 months is 55,785 and the stock's 52-week low/high is $0.078749999/$5.80000019.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a developer and provider of cellular communications solutions for enterprise workers and first responders, today announced the appointment of Jason DePue as VP Sales for AT&T/FirstNet accounts, effective immediately. To view the full press release, visit http://nnw.fm/vL47R

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.245, up 1.6598%, on 6,800 volume with 4 trades. The average volume for the last 3 months is 95,021 and the stock's 52-week low/high is $0.198500007/$0.446249991.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, nonviral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced its plans to attend and present at the Biotech Showcase(TM) 2020, to be held at the Hilton San Francisco Union Square in San Francisco from January 13–15, 2020. To view the full press release, visit http://nnw.fm/LZq1U

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Monday's trading session at $0.302, up 7.4351%, on 908,617 volume with 1,276 trades. The average volume for the last 3 months is 521,843 and the stock's 52-week low/high is $0.231000006/$2.25999999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.